Scientists at the Alzheimer’s Center at Temple at the Lewis Katz School of Medicine at Temple University are on the trail of a promising new therapeutic target – ABCA7, a protein known to protect from Alzheimer’s disease. A new study, published online in the journal Cells, uncovers new information about the relationship between ABCA7, cholesterol and inflammation in human brain cells. Joel Wiener, an investigator with the Alzheimer’s Center at Temple, is first author on the report, and Nicholas Lyssenko, PhD, also an investigator with the Alzheimer’s Center at Temple, is corresponding author. Scienmag and ScienceDaily highlighted the news.
Temple Faculty Physicians is experiencing technical issues with phone lines. If you are experiencing an emergency, please visit your nearest emergency room. If you would like to schedule an appointment with your provider or have general questions or requests, please contact us by using myTempleHealth.
myTempleHealth
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH